Chemical Formula: C35H58O6

Chemical Formula C35H58O6

Found 157 metabolite its formula value is C35H58O6

Stigmasteryl glucoside

(2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(E,1R,4S)-4-ethyl-1,5-dimethyl-hex-2-enyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol

C35H58O6 (574.4233168000001)


Stigmasterol 3-O-beta-D-glucoside is a steroid saponin that is (3beta,22E)-stigmasta-5,22-dien-3-ol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It is isolated from Symplocos lancifolia. It has a role as a metabolite. It is a member of phytosterols, a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a stigmasterol. It derives from a hydride of a stigmastane. Stigmasterol glucoside is a natural product found in Ficus virens, Annona purpurea, and other organisms with data available. A steroid saponin that is (3beta,22E)-stigmasta-5,22-dien-3-ol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It is isolated from Symplocos lancifolia. Isolated from soya bean oil (Glycine max). Stigmasteryl glucoside is found in fats and oils, pulses, and cloves. Stigmasteryl glucoside is found in cloves. Stigmasteryl glucoside is isolated from soya bean oil (Glycine max

   

Clerosterol 3-glucoside

2-{[14-(5-ethyl-6-methylhept-6-en-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


Clerosterol 3-glucoside is found in bitter gourd. Clerosterol 3-glucoside is isolated from fruits of bitter melon (Momordica charantia). Isolated from fruits of bitter melon (Momordica charantia). Clerosterol 3-glucoside is found in bitter gourd and fruits.

   

alpha-Spinasterol 3-glucoside

2-[[17-(5-ethyl-6-methylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


alpha-Spinasterol 3-glucoside is found in fruits. alpha-Spinasterol 3-glucoside is a constituent of Pithecellobium dulce (manila tamarind). Constituent of Pithecellobium dulce (manila tamarind). alpha-Spinasterol 3-glucoside is found in red beetroot and fruits.

   

Isofucosterol glucoside

2-({2,15-dimethyl-14-[(5E)-5-(propan-2-yl)hept-5-en-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


Isofucosterol glucoside is found in garden tomato. Isofucosterol glucoside is a constituent of Lycopersicon esculentum (tomato) Constituent of Lycopersicon esculentum (tomato). Isofucosterol glucoside is found in garden tomato.

   

Tocophersolan

1-(2-hydroxyethyl) 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl butanedioate

C35H58O6 (574.4233168000001)


Vitamin E supplement, antioxidant Tocofersolan (INN) or tocophersolan is a synthetic water-soluble version of vitamin E. Natural forms of vitamin E are fat soluble, but not water-soluble. Tocofersolan is polyethylene glycol derivative of -tocopherol that enables water solubility Vitamin E supplement, antioxidant

   

DG(12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C35H58O6 (574.4233168000001)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C35H58O6 (574.4233168000001)


DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C35H58O6 (574.4233168000001)


DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(i-12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C35H58O6 (574.4233168000001)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

stigmasterol 3-O-beta-D-glucoside

2-{[14-(5-ethyl-6-methylhept-3-en-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


Stigmasterol 3-o-beta-d-glucoside, also known as poriferasterol monoglucoside or substance f, belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. Stigmasterol 3-o-beta-d-glucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Stigmasterol 3-o-beta-d-glucoside can be found in a number of food items such as feijoa, star anise, quinoa, and mentha (mint), which makes stigmasterol 3-o-beta-d-glucoside a potential biomarker for the consumption of these food products. Stigmasterol 3-o-β-d-glucoside, also known as poriferasterol monoglucoside or substance f, belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. Stigmasterol 3-o-β-d-glucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Stigmasterol 3-o-β-d-glucoside can be found in a number of food items such as feijoa, star anise, quinoa, and mentha (mint), which makes stigmasterol 3-o-β-d-glucoside a potential biomarker for the consumption of these food products.

   

22-O-(2-Methylbutanoyl) -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol|22-O-(2-methylbutyroyl)-A1-barrigenol

22-O-(2-Methylbutanoyl) -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol|22-O-(2-methylbutyroyl)-A1-barrigenol

C35H58O6 (574.4233168000001)


   
   

beta-sitosterol-beta-D-glucopyranoside

beta-sitosterol-beta-D-glucopyranoside

C35H58O6 (574.4233168000001)


   
   

24beta(24S)-ethyl-cholesta-4,22-E-diene 3-O-beta-D-glucoside|24beta(24S)-ethyl-cholesta-4-22E-diene 3-O-beta-D-glucoside

24beta(24S)-ethyl-cholesta-4,22-E-diene 3-O-beta-D-glucoside|24beta(24S)-ethyl-cholesta-4-22E-diene 3-O-beta-D-glucoside

C35H58O6 (574.4233168000001)


   
   

Stigmasteryl glucoside

3-O-(beta-D-glucopyranosyl)-stigmast-5,22E-dien-3beta-ol

C35H58O6 (574.4233168000001)


   

Isofucosterol glucoside

2-({2,15-dimethyl-14-[(5E)-5-(propan-2-yl)hept-5-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

alpha-Spinasterol glucoside

2-({14-[(3E)-5-ethyl-6-methylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

Clerosterol glucoside

2-{[14-(5-ethyl-6-methylhept-6-en-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

Tocofersolan

1-(2-hydroxyethyl) 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl butanedioate

C35H58O6 (574.4233168000001)


   

ST 29:2;O;Hex

24E-ethylidene-cholest-5-en-3beta-yl beta-D-glucopyranoside

C35H58O6 (574.4233168000001)


   
   

(E,9R,11R)-9,11-dihydroxy-27-(4-hydroxyphenyl)-2,4-dimethyl-3-oxoheptacos-4-enoic acid

(E,9R,11R)-9,11-dihydroxy-27-(4-hydroxyphenyl)-2,4-dimethyl-3-oxoheptacos-4-enoic acid

C35H58O6 (574.4233168000001)


   

DG(12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C35H58O6 (574.4233168000001)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/12:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/12:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(i-12:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C35H58O6 (574.4233168000001)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-12:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-12:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C35H58O6 (574.4233168000001)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/12:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/12:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/12:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/12:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/12:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/12:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/12:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/12:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/12:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/12:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/12:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C35H58O6 (574.4233168000001)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/12:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/12:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C35H58O6 (574.4233168000001)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-12:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-12:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-12:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-12:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(i-12:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-12:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(i-12:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-12:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-12:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(i-12:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-12:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(i-12:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C35H58O6 (574.4233168000001)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-12:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-12:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(i-12:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C35H58O6 (574.4233168000001)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-12:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-12:0/0:0)

C35H58O6 (574.4233168000001)


   

DG(i-12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(i-12:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C35H58O6 (574.4233168000001)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-12:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-12:0)

C35H58O6 (574.4233168000001)


   

2,3-di(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

2,3-di(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C35H58O6 (574.4233168000001)


   

alpha-Spinasterol 3-glucoside

alpha-Spinasterol 3-glucoside

C35H58O6 (574.4233168000001)


   

TG(32:4)

TG(6:0_6:0_20:4)

C35H58O6 (574.4233168000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

AcHexStE(0:0)

AcHexStE(0:0)

C35H58O6 (574.4233168000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(3r,4s,5s,6r)-2-{[(7s,9ar,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(3r,4s,5s,6r)-2-{[(7s,9ar,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,4e)-5-ethyl-6-methylhept-4-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,4e)-5-ethyl-6-methylhept-4-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3z,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3z,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

5,25-stigmastadien-3beta-ol-beta-d-glucoside

5,25-stigmastadien-3β-ol-β-d-glucoside

C35H58O6 (574.4233168000001)


{"Ingredient_id": "HBIN010973","Ingredient_name": "5,25-stigmastadien-3beta-ol-beta-d-glucoside","Alias": "5,25-stigmastadien-3\u03b2-ol-\u03b2-d-glucoside","Ingredient_formula": "C35H58O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(=C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25253;20330","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

alpha-spinasterol glucoside

NA

C35H58O6 (574.4233168000001)


{"Ingredient_id": "HBIN015684","Ingredient_name": "alpha-spinasterol glucoside","Alias": "NA","Ingredient_formula": "C35H58O6","Ingredient_Smile": "CCC(C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "574.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6875;19516;21517","PubChem_id": "12960505","DrugBank_id": "NA"}

   

β-stigmasteryl 3-O-β-D-glucopyranoside

NA

C35H58O6 (574.4233168000001)


{"Ingredient_id": "HBIN018333","Ingredient_name": "\u03b2-stigmasteryl 3-O-\u03b2-D-glucopyranoside","Alias": "NA","Ingredient_formula": "C35H58O6","Ingredient_Smile": "CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39625","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2s,3z,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2s,3z,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl 2-methylbutanoate

5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl 2-methylbutanoate

C35H58O6 (574.4233168000001)


   

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-ethyl-6-methylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5-ethyl-6-methylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,3e,5r)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,3e,5r)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

2-({19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl}oxy)oxane-3,4,5-triol

2-({19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl}oxy)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

2-{[1-(5-ethyl-6-methylhept-4-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylhept-4-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

2-(hydroxymethyl)-6-{[1-(5-isopropylhept-5-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[1-(5-isopropylhept-5-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2s,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2s,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5ar,7s,9as,9br,11ar)-1-[(2s,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5ar,7s,9as,9br,11ar)-1-[(2s,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-9a,11a-dimethyl-1-[(2r,5s)-5,6,6-trimethylheptan-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-9a,11a-dimethyl-1-[(2r,5s)-5,6,6-trimethylheptan-2-yl]-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C35H58O6 (574.4233168000001)


   

(2s,3r,4s,5s)-2-{[(3s,6r,8s,11r,12s,15s,16r,19r,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5s)-2-{[(3s,6r,8s,11r,12s,15s,16r,19r,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl]oxy}oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2s,3r,4s,5s)-2-{[(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5s)-2-{[(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl]oxy}oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

2-{[1-(5-ethyl-6-methylhept-6-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylhept-6-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(4s,4ar,5s,6r,6as,6br,8ar,10s,12ar,12br,14bs)-5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl (2r)-2-methylbutanoate

(4s,4ar,5s,6r,6as,6br,8ar,10s,12ar,12br,14bs)-5,6,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl (2r)-2-methylbutanoate

C35H58O6 (574.4233168000001)


   

(3r,4s,5s,6r)-2-{[(7s)-1-(5-ethyl-6-methylhept-6-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(3r,4s,5s,6r)-2-{[(7s)-1-(5-ethyl-6-methylhept-6-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,5s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,5s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5z)-5-isopropylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5z)-5-isopropylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

7,8-bis(acetyloxy)-9a,11a-dimethyl-1-(5,6,6-trimethylheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

7,8-bis(acetyloxy)-9a,11a-dimethyl-1-(5,6,6-trimethylheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O6 (574.4233168000001)